Latham & Watkins and Cooley represent MindMed in connection with the proxy contest. Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED) has announced its successful proxy...
You must be a Standard 1 Year member to access this content.
Cooley advised Angion on the deal. Angion, a clinical-stage biopharmaceutical company, announced its definitive merger agreement with Elicio Therapeutics. Elicio will merge with a wholly owned subsidiary...
You must be a Standard 1 Year member to access this content.
Cooley advised Intersect ENT on the deal, while Ropes & Gray advised Medtronic. Intersect ENT, a global ear, nose and throat medical technology leader dedicated to...
You must be a Standard 1 Year member to access this content.
